Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |